This CAR T-cell therapy has revolutionized the management of high-risk and relapsed or refractory disease.
Jordan D. Scott, PharmD
Advertisement
Articles by Jordan D. Scott, PharmD
An interdisciplinary discussion addresses the disparity in availability and use of these therapies across the continuum of care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Trump Executive Order Recommends Separating MMR Into 3 Shots
2
First-in-Class RNA Degrader Targets Historically ‘Undruggable’ MYC in Preclinical Multiple Myeloma Models
3
Suzetrigine-Based Multimodal Therapy Enables Opioid-Free Recovery in Patients Receiving Surgery
4
The Inflation Reduction Act and Oncology Drug Pricing: What Pharmacists Need to Know
5